Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 35,000 shares at $8.04 ($285K) on 2025-09-16, disclosed to the SEC on 2025-09-18.
Open-market sale of $285k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.04 | 10,000 | $80K | 28.2% |
| 2 | $8.04 | 10,000 | $80K | 28.2% |
| 3 | $8.08 | 1,914 | $15K | 5.4% |
| 4 | $8.32 | 3,086 | $26K | 9.0% |
| 5 | $8.33 | 10,000 | $83K | 29.2% |
| Total | $8.15 avg | 35,000 |
| $285K |
| 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2024-12-11 | $294K | — | Filing → |